Pregnancy Outcomes in Patients With Multiple Sclerosis Exposed to Natalizumab—A Retrospective Analysis From the Austrian Multiple Sclerosis Treatment Registry

Objectives: To analyze safety and impact of natalizumab (NTZ) exposure on the disease course, pregnancy, and newborn outcomes of relapsing-remitting multiple sclerosis (RRMS) patients from the Austrian Multiple Sclerosis Treatment Registry (AMSTR). Materials and Methods: Twelve pregnancies of 11 wom...

Descripción completa

Detalles Bibliográficos
Autores principales: Guger, Michael, Traxler, Gerhard, Drabauer, Martina, Leitner-Pohn, Doris, Enzinger, Christian, Leutmezer, Fritz, Oel, Dierk, Di Pauli, Franziska, Berger, Thomas, Ransmayr, Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417297/
https://www.ncbi.nlm.nih.gov/pubmed/32849179
http://dx.doi.org/10.3389/fneur.2020.00676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417297/
https://www.ncbi.nlm.nih.gov/pubmed/32849179
http://dx.doi.org/10.3389/fneur.2020.00676

Ejemplares similares